News|Articles|June 30, 2026
Improving Method Transfer Outcomes (Jun 2026)
Author(s)ACD/Labs
How Pfizer improved HPLC method transfer outcomes using method development software to enhance consistency, efficiency, and reproducibility in workflows across labs.
Related Content
Trending on LCGC International
1
What Determines a Best-in-Class Antibody Drug Conjugate
2
Important Analytical Measurements and Quality by Design for Bioconjugates
3
Framing the Evolving Bioconjugate Landscape
4
What FDA’s 2026 Draft Guidance Means for Antibody Drug Conjugates
5